昭和3年より昭和7年に至る皮膚泌尿器科新來患者の統計的觀察

Clinical subgroup phyla stratified for gender. (DOCX 93 kb

Endoscopic appearance in CD patients presenting with Major and Minor Clinical Criteria.

+<p>Antibody (Ab) for the majority was tTGAb or AEAb, a small number AGAb.</p><p>Ab testing always postoperative for Minor criteria, sometimes pre-operative for Major.</p

Minor Clinical Indicator for Duodenal biopsy.

<p>Minor Clinical Indicator for Duodenal biopsy.</p

Comparison of clinical indication for duodenal biopsy by age.

<p>Comparison of clinical indication for duodenal biopsy by age.</p

Comparison of Clinical Indication for duodenal biopsy by age and gender.

<p>Comparison of Clinical Indication for duodenal biopsy by age and gender.</p

Endoscopic appearance in CD patients presenting with Major and Minor Clinical Criteria.

+<p>Antibody (Ab) for the majority was tTGAb or AEAb, a small number AGAb.</p><p>Ab testing always postoperative for Minor criteria, sometimes pre-operative for Major.</p

Outline of study.

<p>Outline of study.</p

Clinical Indicators among the 35 CD patients.

<p>Clinical Indicators among the 35 CD patients.</p

Additional file 1: Figure S1. of Blastocystis specific serum immunoglobulin in patients with irritable bowel syndrome (IBS) versus healthy controls

Anti-proMMP-9, MAb1D5, MAb5 reacting with Blastocystis proteins in a Western blot. (PDF 292 kb

Additional file 2: Table S1. of Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients

Relative abundance (percentage) of bacterial groups (by sex). (DOCX 144 kb